Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 2Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Genitourinary 10Other hematologic neoplasm 8Lymphoid 7CNS 7Thoracic 5Head & Neck 5Breast 5Plasma cell 3Gynecologic 3Dermatologic 3Classical hematology 3Sarcoma 2Myeloid 2Endocrine 2Tumor-Agnostic 1Other 1

Conditions

Pheochromocytoma 1Paraganglioma 1Cardiomyopathies 1Adrenocortical Carcinoma 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6Nivolumab 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Observation × Endocrine × Clear all
NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT05082311 2022-02-10

PheoCard

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Completed
55 enrolled
CNSEndocrine

Cardiomyopathies, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡